BRIEF published on 10/30/2024 at 09:17, 22 days 4 hours ago L'Oréal successfully issues €1.25 billion bond Euronext Paris Investment Bond Issue Bond Market L'Oréal
PRESS RELEASE published on 10/30/2024 at 09:12, 22 days 4 hours ago L’ORÉAL SUCCESSFULLY PRICES A 1.25 BILLION EURO DUAL TRANCHE BOND L’Oréal successfully prices a 1.25 billion euro dual tranche bond for general corporate purposes, including to refinance part of the Galderma stake acquisition. Bonds rated AA (Stable) by S&P and Aa1 (Stable) by Moody’s Acquisition Rating L'Oréal Bond Offering Dual Tranche Bond
BRIEF published on 09/16/2024 at 15:26, 2 months 4 days ago Disclosure of Voting Rights and Shares at L'Oréal as of August 31, 2024 Share Capital Voting Rights Shares AMF Regulations L'Oréal
PRESS RELEASE published on 09/16/2024 at 15:21, 2 months 4 days ago Disclosure of total number of voting rights and number of shares in the capital at August 31, 2024 L'Oréal discloses total voting rights & shares info. Company overview and contact details provided. Dedicated to beauty innovation and sustainability Financial Information Sustainability L'Oréal Beauty Player Contact Details
BRIEF published on 08/14/2024 at 16:39, 3 months 6 days ago Disclosure of Voting Rights and Shares at L’Oréal as of July 31, 2024 Voting Rights Shares Financial Disclosure 2024 Report L’Oréal
PRESS RELEASE published on 08/14/2024 at 16:34, 3 months 6 days ago Disclosure of total number of voting rights and number of shares in the capital at July 31, 2024 L'Oréal, a leading beauty company, discloses voting rights and shares information. With 115 years in beauty, it focuses on sustainability and innovation Voting Rights Shares Sustainability Beauty L'Oréal
BRIEF published on 08/05/2024 at 07:20, 3 months 16 days ago L’Oréal Group acquires 10% of Galderma Acquisition Strategic Partnership Growth Dermatology Injectable Aesthetics
BRIEF published on 07/15/2024 at 11:44, 4 months 6 days ago Disclosure of Total Number of Voting Rights and Shares at L'Oréal as of June 30, 2024 Voting Rights Capital Shares 2024 L'Oréal
PRESS RELEASE published on 07/15/2024 at 11:39, 4 months 6 days ago Disclosure of total number of voting rights and number of shares in the capital at June 30, 2024 French limited company L'Oréal discloses total voting rights and shares at June 30, 2024. Leading beauty player with a focus on sustainability and innovation. Contact details provided Innovation Voting Rights Shares Sustainability L'Oréal
BRIEF published on 06/17/2024 at 12:14, 5 months 4 days ago L'Oréal: Declaration of voting rights and shares as of May 31, 2024 Voting Rights Capital Actions AMF L'Oréal
Published on 11/21/2024 at 13:30, 27 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 27 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 57 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 57 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 57 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 22 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 42 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
